Phase 2 Metastatic Pancreatic Adenocarcinoma trials recruiting now

All Metastatic Pancreatic Adenocarcinoma trials, every phase

Other phases for Metastatic Pancreatic Adenocarcinoma

Phase 2 Metastatic Pancreatic Adenocarcinoma trials

• BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
  NCT07226856 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
  NCT06576115 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
  NCT03608631 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.